Nitrosamines at FDA's Pharmaceutical Quality Symposium 2021

Nitrosamines were discussed at FDA’s Pharmaceutical Quality Symposium 2021 this week.

Concerns associated with Nitrosamines and related Product Recalls featured in the Keynote address of FDA Commissioner Dr Janet Woodcock yesterday.

Enclosed is the Powerpoint of an interesting session on Control of Nitrosamine Impurities in Human drugs that was conducted today.

D2S01-Rodriguez.pdf (661.8 KB)

2 Likes